As in the cell line and tumoroid models, inhibition of Mediator kinase alone had no effect on in vivo tumor growth or overall toxicity (Supplementary Fig. 5e–g), positioning CDK8/19 co-inhibition as an effective and well-tolerated strategy for preventing resistance to sustained MAPK inhibition. Here, CDK8 is linked to neoplasm.